Akriveia Therapeutics, the health tech company focusing on immunology, has raised $7.5M in Series A funding from F-Prime Capital Partners. This is the company’s first round of funding.
Page 4 of 7
Akriveia Therapeutics, the health tech company focusing on immunology, has raised $7.5M in Series A funding from F-Prime Capital Partners. This is the company’s first round of funding.
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
